Next Article in Journal
The Global Rise of ESBL-Producing Escherichia coli in the Livestock Sector: A Five-Year Overview
Previous Article in Journal
Lesion Localization and Pathological Diagnosis of Ovine Pulmonary Adenocarcinoma Based on MASK R-CNN
Previous Article in Special Issue
Effect of Prepartum Maternal Supplementation with Diphenyl Diselenide on Biochemical, Immunological, and Oxidative Parameters of the Offspring
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Effects of Bacillus subtilis on Growth Performance, Metabolic Profile, and Health Status in Dairy Calves

by
Ramūnas Antanaitis
1,*,
Karina Džermeikaitė
1,
Justina Krištolaitytė
1,
Emilija Armonavičiūtė
1,
Samanta Arlauskaitė
1,
Akvilė Girdauskaitė
1,
Arūnas Rutkauskas
1 and
Walter Baumgartner
2
1
Large Animal Clinic, Veterinary Academy, Lithuanian University of Health Sciences, Tilžės Str. 18, LT-47181 Kaunas, Lithuania
2
Clinical Centre for Ruminant and Camelid Medicine, University of Veterinary Medicine, Veterinaerplatz 1, A-1210 Vienna, Austria
*
Author to whom correspondence should be addressed.
Animals 2024, 14(17), 2489; https://doi.org/10.3390/ani14172489
Submission received: 4 August 2024 / Revised: 19 August 2024 / Accepted: 26 August 2024 / Published: 27 August 2024
(This article belongs to the Special Issue Advances in Calf Health and Performance)

Abstract

:

Simple Summary

This study evaluated the effects of adding the probiotic Bacillus (B.) subtilis to the feed of preweaning neonatal calves. Fifty Holstein calves from the same farm were split into two groups: a control group (CG) fed milk replacer and a treatment group (TG) receiving milk replacer plus 7.5 mL/calf/day of B. subtilis. The study began 24 h after birth, with calves’ health monitored daily. Significant differences in body weight were observed between the CG and the TG at 30, 60, and 90 days of age. The TG had a higher average body weight at each time point. At 30 days, the TG also showed lower AST activity and higher GGT activity compared to the CG. Phosphorus levels were higher in the TG, while total protein concentrations were lower at both 30 and 60 days. The inclusion of B. subtilis in the calves’ diet led to improved growth and a better metabolic profile, suggesting its potential as a beneficial feed additive in dairy farming.

Abstract

This study focused on assessing whether the inclusion of probiotics (B. subtilis) as feed additives during the preweaning stage can enhance the body weight and metabolic condition of neonatal calves. A total of 50 Holstein calves, all born on the same farm, were randomly divided into two homogeneous treatment groups after birth. The calves in the control group (CG) were fed a milk replacer (n = 25) (13 females and 12 males) and those in the B. subtilis-supplement-treated group (TG), (n = 25) (13 females and 12 males) were fed a milk replacer with 7.5 mL/calf/day of B. subtilis probiotic (complied with the manufacturer’s guidelines). The probiotic was administered 24 h post-birth, signifying the start of the experimental period. It took one month to collect the animals. Body weight was measured at birth for all animals. A local veterinarian, working on the farm, conducted daily health checks of the calves, recording health parameters and any antibiotic treatments. Blood samples were collected from each calf at birth and 30, 60, and 90 days by puncturing the jugular vein using 10 mL evacuated serum tubes before morning feeding. Significant differences in body weight were observed between the CG and the TG at 30, 60, and 90 days of age. At 30 days, the TG had a 4.11% higher average body weight than the CG (54.38 kg vs. 52.71 kg). At 60 days, the TG’s average weight was 3.75% higher (79.21 kg vs. 76.34 kg), and at 90 days, the TG had a 2.91% higher average weight (112.87 kg vs. 109.67 kg). At 30 days of age, the TG showed significantly lower AST activity, with a 41.12% decrease compared to the CG (51.02 IU/L vs. 72.00 IU/L). Conversely, GGT activity was significantly higher in the TG by 64.68% (40.64 IU/L vs. 14.35 IU/L). Phosphorus concentration at 30 days was also significantly higher in the TG by 9.36% (3.27 mmol/L vs. 2.99 mmol/L). Additionally, the TG had a significantly lower total protein concentration, with a 21.63% decrease at 30 days (46.32 g/L vs. 56.34 g/L) and a 20.28% decrease at 60 days (48.32 g/L vs. 58.12 g/L) compared to the CG. These findings indicate that dairy calves given conventional milk replacer along with a daily dose of 7.5 mL of B. subtilis probiotic experienced enhanced growth performance and a more favourable metabolic profile during the first 90 days of their lives.

1. Introduction

Many microorganisms, primarily lactic acid bacteria such as Lactobacillus spp. and Bifidobacterium spp., are recognised as probiotics, along with a smaller number of non-lactic acid bacteria, including Bacillus (B.) licheniformis and B. subtilis [1].
Bacillus subtilis is a thermophilic, spore-producing, Gram-positive, motile bacterium with a rod-shaped morphology [2]. B. subtilis is a probiotic strain commonly utilised as a feed supplement for ruminant animals. It can enhance ruminal fermentation and generate a diverse array of enzymes that facilitate intestinal absorption and digestion when administered to cows. In addition to facilitating the digestion of ratio proteins and returning urea to the rumen, Bacillus subtilis stimulates protein synthesis, facilitates the absorption of amino acids and peptides generated during decomposition, and augments the protein count that reaches the intestine [3]. B. subtilis is capable of synthesising polypeptides that exhibit an antagonistic nature towards intestinal microorganisms, thereby significantly enhancing the digestibility of animal feed. This aerobic bacterium maintains the ecological equilibrium of the intestines by consuming oxygen and contributing to an anaerobic environment. This, in turn, promotes the reproduction of dominant bacteria in the intestines.
Probiotics have been shown to have positive effects on health and the economy [4]. B. subtilis is utilised in the feed industry [5] due to its ability to foster favourable changes in intestinal microflora [6], aid in recovery from diarrhoea [7], and enhance average daily growth and feed efficiency [8]. B. subtilis is acknowledged as a potent probiotic in the livestock sector. Research by Jeong and Kim [9] highlighted its effectiveness for broilers, including reducing pathogens and boosting beneficial gut bacteria, alongside improving daily growth and feed efficiency. Kritas et al. [10] demonstrated its positive impact on swine, notably enhancing reproductive performance in sows, which includes improved body condition during pregnancy, minimised weight loss during lactation, and increased piglet birth weight. In the case of dairy cows, the use of B. subtilis has been linked to increased milk production, as noted by Souza et al. [11]. While the exact mechanism of its beneficial effects is not fully understood, it is theorised that B. subtilis may enhance the anaerobic conditions in the gastrointestinal tract by rapidly consuming oxygen during germination, as suggested by Hoa et al. [12]. Feeding B. subtilis to calves may lead to enhanced feed efficiency postweaning through the development of beneficial bacteria in the rumen. More extensive research with a larger sample size is required to confirm this potential benefit [13]. Bacillus subtilis modifies the rumen microbiome, enhances digestion during weaning, and reduces the intensity of diarrhoea [14]. Bacillus species, unique in their ability to form spores that resist harsh environments and attract scientific interest, have been proposed for oral administration to improve feed efficiency, immune response, and growth performance [1]. Although probiotics derived from Bacillus spp. have been used for more than seven decades, scientific attention has increased dramatically in recent decades [15]. Administering colostrum and milk replacer containing a combination of probiotics and phytobiotics to dairy calves during the preweaning period improved their health, intake, growth, and metabolic status, in contrast to separate additions of phytobiotics (with rosmarinic acid) and multi-strain Lactobacillus probiotics, which showed no significant impact on feed intake, growth, or physiological indices, suggesting a synergistic effect of the combined treatment that requires further investigation in larger field trials [16]. The blend of probiotics and phytobiotics enhanced the metabolic health of dairy calves [16]. An in vitro study indicated the potential of Bacillus subtilis, likely through its production of catalase and subtilisin, as suggested by Hosoi et al. [17]. According to Wang et al. [18], future research is needed to confirm the effects of live Bacillus additives in vivo to assess additional live Bacillus additives for enhancing rumen fermentation, and to elucidate the mechanisms by which Bacillus additives affect ruminants. The impact of feeding B. subtilis needs to be assessed to more clearly demonstrate the effects of these probiotics [1].
By examining the impact of probiotics on the diversity of intestinal microbiota, we can gain a deeper understanding of the correlation that exists between probiotics, the structure of microbial communities, and overall health [19].
The present study focused on assessing whether the inclusion of probiotics (Bacillus subtilis) as feed additives during the first 90 days of age can improve growth performance, metabolic profile, and health status of dairy calves.

2. Materials and Methods

2.1. Calf Management and Feeding

The research was executed from October 2023 to March 2024 at a dairy farm situated in the western region of Lithuania. The experimental protocols were executed in adherence to the legal requirements of Lithuania. The study received approval under the number PK012858. After birth, a total of 50 (26 males and 24 females) Holstein calves were randomly allocated into two homogeneous treatment groups. All calves came from the same farm. Upon birth, the calves were promptly isolated from their mothers and placed in individual calf hutches in a naturally ventilated barn. It took one month to collect the animals. Every day, the pens were cleaned, and dung was taken away, so they always looked clean and dry. A stomach tube was used to administer 4 L of colostrum to calves within the first hour of life and weighed within 2 h after birth. Culpable colostrum from the mother (≥23 BRIX) was administered to the calves; if the colostrum failed to meet the quality standards, then frozen colostrum was used. Only calves in good health before the study were included in the research. The trial began after birth with the administration of probiotics and lasted until the calf reached 30 days old. Calves were fed individually two times a day. Calves received 3.5 L of milk replacer at each feeding. Replacement milk (Vilomilk-50, Mørke, Denmark) was supplied at 6 A.M. and 6 P.M. The milk substitute was dissolved in hot water (50–60 °C) and administered once the temperature reached around 40 °C. Using a commercial milk replacer (Vilomilk-50, Mørke, Denmark) containing vegetable fat (18.0%), hydrolysed wheat protein concentrate (7.5%), dextrose (2%), vitamins, and trace elements (2.5%), 150 g of milk replacer was combined with one litre of water to make the milk replacer and blended prior to each feeding in accordance with the guidelines provided by the manufacturer. The composition of the milk replacer is presented in Table 1. Throughout the investigation, the experimental feed additive (probiotic) 7.5 mL/calf/day was mixed into the milk substitute just prior to administration. Each calf ingested an equal daily portion of milk replacer. Calves had free access to water. From day 5 to day 30 of the trial, the calves were provided with unlimited access to pelleted starter feed (Table 2).
The weaning procedure was conducted gradually over a span of four days, commencing at 56 days and concluding at 60 days of age.

2.2. Creation of Groups

The animals were administered the probiotic twenty-four hours after birth, marking the beginning of the experiment period. The calves in the control group (CG) were fed a milk replacer (n = 25) (13 females and 12 males) and the B. subtilis-supplement-treated group (TG), (n = 25) (13 females and 12 males) was fed a milk replacer with 7.5 mL/calf/day of B. subtilis probiotic (concentrated solution of Bacillus subtilis probiotics suitable for calf drinking (Bacillus subtilis 5 × 107 CFU/mL), UAB Recaidus, Vilniaus g.20–5, Vilnius, Lithuania)). Following delivery, the calves were assigned to either of the two groups in a random manner. Calves in the TG were given probiotics until they were 30 days old, before being weaned. The probiotics were introduced into the morning milk feeding pail.

2.3. Measurements

Animals were measured for their weight upon birth and at 15, 30, 60, and 90 days old using a scale (AGRETO Animal Scale, AGRETO Electronics GmbH, Raabs, Austria). The health status of the calves was checked daily by a local veterinarian working on the farm, and health parameters and treatment events (with antibiotics for calves exhibiting clinical symptoms related to bacterial respiratory infections or diarrhoea) were recorded. Calves were monitored daily to assess their health condition. Calves experiencing diarrhoea were administered electrolyte solution, and in cases where it was deemed required, antibiotic treatment was administered. Health and nutritional characteristics, including faecal consistency and body temperature, were assessed. These parameters were analysed based on the research methodology of Salah et al. [20]. We utilised faecal score as a criterion for diarrhoea, following the method outlined by Magalhães et al. [21]. In short, faecal consistency was rated as follows: 1 for hard, 2 for soft or moderate, 3 for runny or mild diarrhoea, and 4 for watery and profuse diarrhoea. Criteria for respiratory disorders were established in accordance with the Wisconsin Health Scoring Grid, as delineated by Vandermeulen et al. [22].
A body temperature over 39.5 °C was classified as a fever. Recorded were gastrointestinal symptoms such as loose stool and respiratory symptoms such as coughing and nasal discharge.
Blood samples were obtained from each calf (n = 50) at birth and 30, 60, and 90 days by puncturing the jugular vein using 10 mL evacuated serum tubes to collect blood prior to morning feeding. Blood samples were taken from the jugular vein using an evacuated tube without any anticoagulant (BD Vacutainer®, Eysin, Switzerland). The blood samples were transported at a temperature of 4 °C to the Laboratory of Clinical Tests at the Large Animal Clinic of the Veterinary Academy of the Lithuanian University of Health Sciences within one hour of being collected for subsequent examination. Following this, in the laboratory, the blood samples underwent centrifugation for a duration of 10 to 15 min at a speed of 1500× g. After feeding colostrum, a portable refractometer (RHC200, Yhequipment, Shenzhen, China) was used to measure the IgG level in the sample serum and look for passive transfer of immunity. This was achieved by placing 1–2 drops of the serum fraction onto a refractometer, following the method reported by Renaud et al. [23]. The activities of gamma-glutamyl transferase (GGT) and aspartate transaminase (AST) and the quantities of iron (Fe), calcium (Ca), magnesium (Mg), phosphorus (P), albumin (ALB), and total protein (TP) were determined in blood serum using a Hitachi 705 analyser (Hitachi, Tokyo, Japan) and DiaSys reagents (Diagnostic Systems GmbH, Berlin, Germany).

2.4. Statistical Analysis

The statistical analysis for this study was carried out using IBM SPSS Statistics for Windows, Version 25.0, developed by IBM Corp. in 2017 and based in Armonk, NY, USA. The Shapiro–Wilk test was utilised to ensure the data’s normal distribution. A repeated-measures analysis of variance (ANOVA) test was performed to compare the mean values across the investigated variables. The results were expressed as the mean and standard error of the mean (S.E.M.), with a set significance level of 0.05 (p < 0.05) for determining probability.

3. Results

3.1. Impact of Bacillus Subtilis on Growth of Dairy Calves during the First 90 Days of Life

Significant differences in body weight were observed at 30, 60, and 90 days of age (p < 0.05). At 30 days, the control group (CG) averaged 52.71 kg (±10.68), while the test group (TG) averaged 54.38 kg (±12.34), a difference of 1.67 kg, representing a 4.11% increase. At 60 days, the CG averaged 76.34 kg (±2.05) compared to 79.21 kg (±1.86) in the TG, a difference of 2.87 kg, or a 3.75% increase. At 90 days, the CG averaged 109.67 kg (±1.67), whereas the TG averaged 112.87 kg (±1.95), a difference of 3.2 kg, representing a 2.91% increase. There were no significant differences in body weight among the calves at 0 days or 15 days of age (Table 3).

3.2. Impact of Bacillus subtilis on the Faecal Score of Dairy Calves During the First 90 Days of Life

During the current study, we did not find any statistically significant differences in faecal scores between the investigated groups. The largest differences were observed at 15 days of age, but they were not significant (Table 4).

3.3. Impact of Bacillus subtilis on the Respiratory and Digestive Disorders of Dairy Calves during the First 90 Days of Life

According to our results, we found a higher incidence of digestive diseases in the CG at 15 days of age and an increase in respiratory disorders at 30 days of age (Table 5).

3.4. Impact of Bacillus subtilis on Blood Biochemical Parameters of Dairy Calves during the First 90 Days of Life

AST activity. During this study, significantly lower AST activity was observed in the TG in calves at 30 days of age (p < 0.001). During this period, the average AST activity in the CG was 72.00 IU/L (±12.68), while in the TG it was 51.02 IU/L (±5.16). The difference in AST activity between the groups was 20.98 IU/L, representing a 41.12% decrease. There were no significant differences in AST activity at 0, 60, or 90 days of age in calves (Table 6).
GGT activity. In this study, we found a statistically significant (p < 0.001) increase in gamma-glutamyl transferase activity in the TG compared to the CG at 30 days of age. The GGT activity was 64.68% (or 26.29 IU/L) higher in the TG. The average GGT activity in the TG was 40.64 IU/L (±22.43), while in the CG it was 14.35 IU/L (±3.45). There were no significant differences in GGT activity at 0 days, 60 days, or 90 days of age in calves (Table 7).
Phosphorus. We detected that the average phosphorus concentration in the TG at 30 days of age was significantly (p < 0.001) higher by 0.28 mmol/L, corresponding to a 9.36% increase compared to the CG. In the TG, the concentration was 3.27 mmol/L (±0.22), while in the CG it was 2.99 mmol/L (±0.27). There were no significant differences in phosphorus concentration at 0 days, 60 days, or 90 days of age in calves (Table 8).
Total protein. We observed a significant decrease of 21.63% (or 10.02 g/L) in TP concentration in the TG compared to the CG at 30 days of age. The average TP concentration in the TG was 46.32 g/L (±17.43), whereas in the CG it was 56.34 g/L (±9.81). Additionally, we found a significantly lower TP concentration in the TG (average: 48.32 g/L ± 2.29) compared to the CG (average: 58.12 g/L ± 1.55), with a reduction of 9.8 g/L or 20.28% at 60 days of age. There were no significant differences in total protein concentration at 0 days of age in calves (Table 9).

4. Discussion

4.1. The Influence of Bacillus subtilis on Growth of Dairy Calves during the Initial 90 Days of Life

Statistically significant disparities in body weight were noted at 30, 60, and 90 days of age (p < 0.05). According to our results, we found a higher body weight in the TG compared to the CG, with differences of 3.07% at 30 days of age, 3.64% at 60 days of age, and 2.8% at 90 days of age.
Calf growth performance is a crucial metric for assessing the efficacy of feed additives utilised by producers. By functioning as feed additives, probiotics have the capacity to modulate intestinal flora, augment gastrointestinal digestion and absorption, subsequently enhancing animal growth performance and feed conversion rate [24]. Probiotics have the potential to promote intestinal flora balance in animals by stimulating the production of biologically active substances, increasing the abundance of beneficial bacteria, and decreasing the abundance of pathogenic bacteria [25]. Probiotics primarily work by restoring the balance of gut flora and outcompeting harmful bacteria for resources and space, therefore hindering their growth and colonisation. Moreover, probiotics create antimicrobial compounds like organic acids and bacteriocins, regulate the immune system by promoting the production of cytokines and other immune agents, enhance the intestinal epithelial barrier, assist in digestion by producing enzymes that help break down complex molecules, and produce short-chain fatty acids associated with enhanced digestibility and nutrient uptake [26]. Probiotics, widely used as feed additives, play a significant role in forming protective microflora in the gastrointestinal tract of calves. Since the ruminal microorganisms in calves include various bacteria, the hypothesis is that compound probiotics could be beneficial. Therefore, a commercial compound probiotic product was used in this study to assess its impact on Holstein calves [3]. Bacillus spp. cultures are utilised in feed additives for enhancing feed digestibility and preventing diseases in industrial cattle husbandry. This practice aims to reduce antibiotic usage, which significantly contributes to animal preservation and productivity. The inclusion of yeasts in feed promotes the growth of anaerobic bacteria, as the respiratory activity of yeasts shields these bacteria in the rumen from damage caused by oxygen [27].
The findings of this study, along with insights from previous research [28,29,30,31,32], indicate that the management and health status of calves play a role in the effectiveness of probiotics on their growth performance. Sun et al. [33] found that the oral administration of B. subtilis to calves led to enhanced feed efficiency and an increase in their average daily weight gain. Administering B. subtilis natto directly to calves in the preweaning phase improved their growth by enhancing average daily gain and feed efficiency. Additionally, it led to earlier weaning of the calves, all without any negative effects [33]. According to the study of Wu et al., the treated groups had a higher total feed intake compared to the control group, likely due to the enhanced bioavailability of multispecies probiotics that produce organic acids, metabolites, enzymes, and essential nutrients during animal metabolism [34]. In addition, probiotics are thought to indirectly promote the developmental process and fermentation of the reticulorumen. This might lead to higher intake of feed, which may change the microbial population in the rumen [16]. Research on chickens has demonstrated that Bacillus subtilis can suppress the growth of pathogenic microorganisms and enhance digestive enzyme activity, leading to a reduction in ammonia production. These effects, in turn, have been shown to improve the growth performance of poultry [33].
Noori et al. [35] discovered that probiotics can enhance the withers height in Holstein calves. This improvement might be attributed to probiotics, which potentially increase the bioavailability of essential minerals like calcium, phosphorus, and magnesium, thereby contributing to the growth of body size. Bacillus species are thought to mitigate pathogen colonisation by activating essential survival pathways and boosting the immune response in epithelial cells, as noted by Williams [36] and Piewngam et al. [37]. However, the impact of probiotics on the growth and health of calves remains uncertain and varies significantly. This variability is often due to differences in the species of probiotics used, the number of viable probiotic bacteria, and the methods of administration, as discussed by Diao et al. [38]. Our study focuses only on body weight data, but it might be improved by including a data analysis of feed intake, rumen fermentation, or bacterial community for a more comprehensive analysis. We recommend including these data in future studies.

4.2. The Influence of Bacillus subtilis on the Faecal Score of Dairy Calves in the Initial 90 Days of Life

In the present study, no statistically significant disparities in faecal scores were seen across the groups under investigation. The most notable disparities were noted at 15 days of age, although they were not statistically significant. The faecal score system is a frequently employed method for predicting the occurrence of diarrhoea in young animals [23]. According to Cho and Yoon [39], diarrhoea in preweaning dairy calves is linked to illness, difficulty absorbing nutrients, and reduced productivity in the future. The current investigation revealed that calves experienced several ailments such as diarrhoea, fever, pneumonia, and cough. Diarrhoea is closely associated with inflammation of the gastrointestinal system and has a significant impact on the growth performance of calves [40]. The main problem during the first three weeks of birth is acute diarrhoea, which is then replaced by respiratory disease at about four weeks of age [41]. A study conducted by Medrano-Galarza et al. [42] found that the prevalence of diarrhoea in calves varied between 16% and 27% depending on the season of birth. The average prevalence throughout all seasons was 23%. Furthermore, the prevalence of diarrhoea within a herd was greater than within a pen, with average rates of 23.75% and 17.75%, respectively. The current study found that the incidence of diarrhoea in calves was 12.54%, which was comparatively lower than in previous studies. The health of calves was enhanced by a diet that included compound probiotics, as seen by a reduction in faecal score and the need for medical treatments. Therefore, it is advisable to administer a substantial amount of compound probiotics to enhance the growth and well-being of newly born Holstein calves [3]. Proper feeding management is crucial in preventing viral illnesses and promoting the healthy growth of calves due to their immature immune system [13]. For probiotics to be successfully implemented in calf production, it is critical to identify probiotic bacteria that function as feed additives and to elucidate the mechanisms by which these probiotics influence the intestinal microbiota and immunity of the host to enhance health and performance [43]. The importance of probiotics stems from the significant role a host’s microflora plays in determining susceptibility to diseases, influencing the health of the intestines either positively or negatively [44].

4.3. The Influence of Bacillus subtilis on Blood Biochemical Parameters of Dairy Calves during the Initial 90 Days of Life

4.3.1. The Influence of Bacillus subtilis on AST Activity of Dairy Calves during the Initial 90 Days of Life

According to our results, the disparity in AST (aspartate aminotransferase) activity across the groups was 20.98 IU/L, indicating a reduction of 41.12% in the TG. Blood AST activities are a crucial metric for assessing liver function, with heightened AST activity signalling liver impairment [45]. AST, an enzyme prevalent in various tissues and organs and particularly active in the liver [46], shows elevated activity in the serum as an indicator of liver or skeletal muscle injury [47]. The levels of hepatic AST rise during pathological events, leading to the release of these enzymes into the bloodstream [48]. Typically, in animals, the generation and neutralisation of free radicals maintain a dynamic equilibrium under normal physiological circumstances, but an overabundance of free radicals can result in oxidative stress [18,49]. According to Wu et al. [34], results with Sprague-Dawley rats involved oral administration of probiotic Bacillus SC06, which decreased activities of alanine transaminase (ALT), AST, alkaline phosphatase (ALP), and lactate dehydrogenase (LDH) and suppressed mitochondrial dysfunction. Studies with lambs and sheep demonstrated reduced activities of AST in the group that was fed Bacillus subtilis [50]. In another study by Choonkham et al. [51], it was discovered that cows given additional B. subtilis had reduced levels of creatinine and albumin and showed a tendency towards decreased AST and β-hydroxybutyrate concentrations. Additionally, these results clarify the processes through which probiotics mitigate oxidative stress and offer a potentially effective approach to averting liver diseases through the modulation of intestinal microbiota [34].

4.3.2. The Influence of Bacillus subtilis on GGT Activity of Dairy Calves during the Initial 90 Days of Life

Our study revealed a significant (p < 0.001) rise in GGT activity in the TG compared to the CG at 30 days of age. The GGT activity in the TG was 64.48% greater compared to the reference value of 26.29 IU/L. Mert et al. [52] found that serum GGT activity can be a reliable indicator for assessing passive transfer status in newborn calves. While total protein and urea levels on their own might not provide complete information, they could be useful when evaluated in conjunction with GGT activity. GGT is known to be produced by the cells lining the secretory ducts of the mammary glands. This has led to the understanding that GGT, much like immunoglobulins, is absorbed from the intestines. Previous studies have highlighted that the level of GGT activity in colostrum is significantly higher, by about 400–800 times, than in the serum of adult animals. It has been reported that in calves that consume colostrum, the serum GGT activity is observed to be 60–160 times higher than in adult animals [52].

4.3.3. The Influence of Bacillus subtilis on Phosphorus Concentration of Dairy Calves during the Initial 90 Days of Life

Our analysis revealed that the mean phosphorus level in the TG at 30 days old was significantly (p < 0.001) elevated by 9.36% compared to the CG. Zhang et al. [1] also found a greater phosphorus concentration in calves fed Lactobacillus plantarum and B. subtilis compared to the control group. Administering probiotics during the weaning stage may aid in the development of the ruminal bacterial community, as suggested by Krehbiel et al. [53]. This could potentially enhance the utilisation of nutrients [54]. Hosoi et al. [17] observed that in vitro supplementation with B. subtilis could enhance the quantity and activity of lactic acid bacteria. However, due to the complex nature of the bacterial community in the rumen, influenced by diet, environmental factors, and the physiological and health status of ruminants, further investigation into rumen fermentation and bacterial community changes is needed. Additionally, assessing the effect of B. subtilis alone is crucial for a clearer understanding of the associative impacts of these probiotics [54].

4.3.4. The Influence of Bacillus subtilis on Total Protein Concentration of Dairy Calves during the Initial 90 Days of Life

At 30 days of age, we saw a substantial reduction of 17.7% in TP content in the TG when compared to the CG. In addition, we observed a significantly reduced concentration of TP in the TG compared to the CG, with a decrease of 30% at 60 days of age. Most of the probiotics in the milk replacer bypassed the rumen due to the closure of the oesophageal groove, affecting intestinal bacteria. Fuller [55] noted that probiotics are particularly effective in the presence of a microbial population, especially under stress [54]. Administering probiotics during the weaning stage may assist in the growth of the bacterial community within the rumen, according to Krehbiel et al. [53]. This could potentially lead to better nutrient utilisation [54].
Further research, sample collection, and experimentation could be implemented to broaden the scope of this study. It might be beneficial to evaluate blood urea nitrogen (BUN), since it is the primary product of protein metabolism. A higher protein intake results in increased protein breakdown into amino acids, which are then converted into urea and discharged into the bloodstream [56]. Weaned calves supplemented with Lactobacillus probiotics showed significantly elevated BUN levels compared to the control group on days 7 and 14, suggesting increased amino acid metabolism and delayed nitrogen excretion [57]. Meanwhile, the relationship between urea nitrogen levels in newborn calf serum and protein intake fluctuates. The fluctuation in blood urea nitrogen levels in calves is influenced by the interplay between their energy levels and protein consumption. Calves may deaminate amino acids to produce carbon skeletons for gluconeogenesis [58]. Exploring the use of plasma urea levels to evaluate protein utilisation in future studies, particularly in calves given probiotics, might be advantageous.
Studying has some limitations. Our study has a relatively small sample size, which might limit the generalisability of the findings. Additionally, the study primarily focuses on short-term outcomes, leaving the long-term effects of Bacillus subtilis supplementation on the health and development of calves largely unexplored.

5. Conclusions

The findings indicate that dairy calves who were given conventional milk replacer along with a daily dose of 7.5 mL of B. subtilis probiotic experienced enhanced growth performance and a more favourable metabolic profile over the initial 90 days of their lives. The TG exhibited consistently higher body weights compared to the CG at 30, 60, and 90 days of age, with increases of 4.11%, 3.75%, and 2.91%, respectively, indicating enhanced growth. Additionally, the TG demonstrated improved liver health, as evidenced by a 41.12% reduction in AST activity at 30 days, and better protein metabolism, as shown by a 64.68% increase in GGT activity and a 9.36% increase in phosphorus concentration.
Future studies should prioritise increasing the sample size and including additional blood biochemical parameters such as urea, glucose, cholesterol, triglycerides, and others to ensure more reliable and conclusive findings, as well as investigating the long-term impacts of Bacillus subtilis supplementation on dairy calves.

Author Contributions

R.A.: supervision of the whole study, writing—review and editing, and software; K.D., J.K., S.A., A.G., A.R. and E.A.: data collection and investigation; W.B.: review and editing. All authors have read and agreed to the published version of the manuscript.

Funding

Ministry of Agriculture of the Republic of Lithuania. Project number MTE-23-10.

Institutional Review Board Statement

This study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee (the study approval number is PK016965. 2017.06.06).

Informed Consent Statement

Written informed consent has been obtained from the owner of the animals involved in this study.

Data Availability Statement

The original contributions presented in the study are included in the article, further inquiries can be directed to the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Zhang, J.; Deng, L.X.; Zhang, H.L.; Hua, G.H.; Han, L.; Zhu, Y.; Meng, X.J.; Yang, L.G. Effects of Parity on Uterine Involution and Resumption of Ovarian Activities in Postpartum Chinese Holstein Dairy Cows. J. Dairy Sci. 2010, 93, 1979–1986. [Google Scholar] [CrossRef]
  2. Mielich-Süss, B.; Lopez, D. Molecular Mechanisms Involved in Bacillus subtilis Biofilm Formation. Environ. Microbiol. 2015, 17, 555–565. [Google Scholar] [CrossRef] [PubMed]
  3. Wang, Z.; He, Z.; Beauchemin, K.A.; Tang, S.; Zhou, C.; Han, X.; Wang, M.; Kang, J.; Odongo, N.E.; Tan, Z. Comparison of Two Live Bacillus Species as Feed Additives for Improving in vitro Fermentation of Cereal Straws. Anim. Sci. J. 2016, 87, 27–36. [Google Scholar] [CrossRef] [PubMed]
  4. Cull, C.; Singu, V.K.; Cull, B.J.; Lechtenberg, K.F.; Amachawadi, R.G.; Schutz, J.S.; Bryan, K.A. Efficacy of Two Probiotic Products Fed Daily to Reduce Clostridium Perfringens-Based Adverse Health and Performance Effects in Dairy Calves. Antibiotics 2022, 11, 1513. [Google Scholar] [CrossRef]
  5. Authority (EFSA), E.F.S. Scientific Opinion on the Overall Effects of Farming Systems on Dairy Cow Welfare and Disease. EFSA J. 2009, 7, 1143. [Google Scholar] [CrossRef]
  6. Maruta, K.; Miyazaki, H.; Tadano, Y.; Masuda, S.; Suzuki, A.; Takahashi, H.; Takahashi, M. Effects of Bacillus subtilis C-3102 Intake on Fecal Flora of Sows and on Diarrhea and Mortality Rate of Their Piglets. Anim. Sci. Technol. 1996, 67, 403–409. [Google Scholar] [CrossRef]
  7. Jiraphocakul, S.; Sullivan, T.W.; Shahani, K.M. Influence of a Dried Bacillus subtilis Culture and Antibiotics on Performance and Intestinal Microflora in Turkeys1. Poult. Sci. 1990, 69, 1966–1973. [Google Scholar] [CrossRef] [PubMed]
  8. La Ragione, R.M.; Narbad, A.; Gasson, M.J.; Woodward, M.J. In Vivo Characterization of Lactobacillus johnsonii FI9785 for Use as a Defined Competitive Exclusion Agent against Bacterial Pathogens in Poultry. Lett. Appl. Microbiol. 2004, 38, 197–205. [Google Scholar] [CrossRef] [PubMed]
  9. Jeong, J.S.; Kim, I.H. Effect of Bacillus subtilis C-3102 Spores as a Probiotic Feed Supplement on Growth Performance, Noxious Gas Emission, and Intestinal Microflora in Broilers. Poult. Sci. 2014, 93, 3097–3103. [Google Scholar] [CrossRef]
  10. Kritas, S.K.; Marubashi, T.; Filioussis, G.; Petridou, E.; Christodoulopoulos, G.; Burriel, A.R.; Tzivara, A.; Theodoridis, A.; Pískoriková, M. Reproductive Performance of Sows Was Improved by Administration of a Sporing Bacillary Probiotic (Bacillus subtilis C-3102). J. Anim. Sci. 2015, 93, 405–413. [Google Scholar] [CrossRef]
  11. Souza, V.L.; Lopes, N.M.; Zacaroni, O.F.; Silveira, V.A.; Pereira, R.A.N.; Freitas, J.A.; Almeida, R.; Salvati, G.G.S.; Pereira, M.N. Lactation Performance and Diet Digestibility of Dairy Cows in Response to the Supplementation of Bacillus subtilis Spores. Livest. Sci. 2017, 200, 35–39. [Google Scholar] [CrossRef]
  12. Hoa, N.T.; Baccigalupi, L.; Huxham, A.; Smertenko, A.; Van, P.H.; Ammendola, S.; Ricca, E.; Cutting, S.M. Characterization of Bacillus Species Used for Oral Bacteriotherapy and Bacterioprophylaxis of Gastrointestinal Disorders. Appl. Environ. Microbiol. 2000, 66, 5241–5247. [Google Scholar] [CrossRef] [PubMed]
  13. Koike, S.; Ueno, M.; Ashida, N.; Imabayashi, T.; Kobayashi, Y. Effect of Bacillus subtilis C-3102 Supplementation in Milk Replacer on Growth and Rumen Microbiota in Preweaned Calves. Anim. Sci. J. 2021, 92, e13580. [Google Scholar] [CrossRef]
  14. Lucey, P.M.; Lean, I.J.; Aly, S.S.; Golder, H.M.; Block, E.; Thompson, J.S.; Rossow, H.A. Effects of Mannan-Oligosaccharide and Bacillus subtilis Supplementation to Preweaning Holstein Dairy Heifers on Body Weight Gain, Diarrhea, and Shedding of Fecal Pathogens. J. Dairy Sci. 2021, 104, 4290–4302. [Google Scholar] [CrossRef]
  15. Goetz, B.M.; Abeyta, M.A.; Rodriguez-Jimenez, S.; Opgenorth, J.; McGill, J.L.; Fensterseifer, S.R.; Arias, R.P.; Lange, A.M.; Galbraith, E.A.; Baumgard, L.H. Effects of a Multistrain Bacillus-Based Direct-Fed Microbial on Gastrointestinal Permeability and Biomarkers of Inflammation during and Following Feed Restriction in Mid-Lactation Holstein Cows. J. Dairy Sci. 2024, 107, 6192–6210. [Google Scholar] [CrossRef]
  16. Stefańska, B.; Sroka, J.; Katzer, F.; Goliński, P.; Nowak, W. The Effect of Probiotics, Phytobiotics and Their Combination as Feed Additives in the Diet of Dairy Calves on Performance, Rumen Fermentation and Blood Metabolites during the Preweaning Period. Anim. Feed Sci. Technol. 2021, 272, 114738. [Google Scholar] [CrossRef]
  17. Hosoi, T.; Ametani, A.; Kiuchi, K.; Kaminogawa, S. Improved Growth and Viability of Lactobacilli in the Presence of Bacillus subtilis (Natto), Catalase, or Subtilisin. Can. J. Microbiol. 2000, 46, 892–897. [Google Scholar] [CrossRef] [PubMed]
  18. Wang, X.P.; Luoreng, Z.M.; Zan, L.S.; Raza, S.H.A.; Li, F.; Li, N.; Liu, S. Expression Patterns of miR-146a and miR-146b in Mastitis Infected Dairy Cattle. Mol. Cell. Probes 2016, 30, 342–344. [Google Scholar] [CrossRef]
  19. Liu, B.; Wang, C.; Huasai, S.; Han, A.; Zhang, J.; He, L.; Aorigele, C. Compound Probiotics Improve the Diarrhea Rate and Intestinal Microbiota of Newborn Calves. Animals 2022, 12, 322. [Google Scholar] [CrossRef]
  20. Salah, N.; Legendre, H.; Nenov, V.; Briche, M.; Serieys, F.; Grossi, S.; Sgoifo Rossi, C.A. Does Micro-Granulated Yeast Probiotic (Saccharomyces cerevisiae) Supplementation in Milk Replacer Affect Health, Growth, Feed Efficiency and Economic Gain of Calves? Vet. Anim. Sci. 2024, 23, 100329. [Google Scholar] [CrossRef]
  21. Magalhães, V.J.A.; Susca, F.; Lima, F.S.; Branco, A.F.; Yoon, I.; Santos, J.E.P. Effect of Feeding Yeast Culture on Performance, Health, and Immunocompetence of Dairy Calves. J. Dairy Sci. 2008, 91, 1497–1509. [Google Scholar] [CrossRef]
  22. Vandermeulen, J.; Bahr, C.; Johnston, D.; Earley, B.; Tullo, E.; Fontana, I.; Guarino, M.; Exadaktylos, V.; Berckmans, D. Early Recognition of Bovine Respiratory Disease in Calves Using Automated Continuous Monitoring of Cough Sounds. Comput. Electron. Agric. 2016, 129, 15–26. [Google Scholar] [CrossRef] [PubMed]
  23. Renaud, D.L.; Steele, M.A.; Genore, R.; Roche, S.M.; Winder, C.B. Passive Immunity and Colostrum Management Practices on Ontario Dairy Farms and Auction Facilities: A Cross-Sectional Study. J. Dairy Sci. 2020, 103, 8369–8377. [Google Scholar] [CrossRef]
  24. Yao, J.; Wang, L.; Zhang, W.; Liu, M.; Niu, J. Effects of Bacillus megaterium on Growth Performance, Serum Biochemical Parameters, Antioxidant Capacity, and Immune Function in Suckling Calves. Open Life Sci. 2020, 15, 1033–1041. [Google Scholar] [CrossRef] [PubMed]
  25. Liu, J.; Li, L.; Chen, X.; Lu, Y.; Wang, D. Effects of Heat Stress on Body Temperature, Milk Production, and Reproduction in Dairy Cows: A Novel Idea for Monitoring and Evaluation of Heat Stress—A Review. Asian-Australas. J. Anim. Sci. 2019, 32, 1332–1339. [Google Scholar] [CrossRef]
  26. Evangelista, A.G.; Nazareth, T.d.M.; Luz, C.; Dopazo, V.; Moreno, A.; Riolo, M.; Meca, G.; Luciano, F.B. The Probiotic Potential and Metabolite Characterization of Bioprotective Bacillus and Streptomyces for Applications in Animal Production. Animals 2024, 14, 388. [Google Scholar] [CrossRef]
  27. Newbold, C.J.; Wallace, R.J.; Mcintosh, F.M. Mode of Action of the Yeast Saccharomyces Cerevisiae as a Feed Additive for Ruminants. Br. J. Nutr. 1996, 76, 249–261. [Google Scholar] [CrossRef]
  28. Cruywagen, C.W.; Jordaan, I.; Venter, L. Effect of Lactobacillus acidophilus Supplementation of Milk Replacer on Preweaning Performance of Calves. J. Dairy Sci. 1996, 79, 483–486. [Google Scholar] [CrossRef] [PubMed]
  29. Abu-Tarboush, H.M.; Al-Saiady, M.Y.; Keir El-Din, A.H. Evaluation of Diet Containing Lactobacilli on Performance, Fecal Coliform, and Lactobacilli of Young Dairy Calves. Anim. Feed Sci. Technol. 1996, 57, 39–49. [Google Scholar] [CrossRef]
  30. Khuntia, A.; Chaudhary, L.C. Performance of Male Crossbred Calves as Influenced by Substitution of Grain by Wheat Bran and the Addition of Lactic Acid Bacteria to Diet. Asian-Australas. J. Anim. Sci. 2002, 15, 188–194. [Google Scholar] [CrossRef]
  31. Timmerman, H.M.; Mulder, L.; Everts, H.; van Espen, D.C.; van der Wal, E.; Klaassen, G.; Rouwers, S.M.G.; Hartemink, R.; Rombouts, F.M.; Beynen, A.C. Health and Growth of Veal Calves Fed Milk Replacers with or without Probiotics. J. Dairy Sci. 2005, 88, 2154–2165. [Google Scholar] [CrossRef] [PubMed]
  32. Frizzo, L.S.; Bertozzi, E.; Soto, L.P.; Sequeira, G.J.; Rodriguez Armesto, R.; Rosmini, M.R. Studies on Translocation, Acute Oral Toxicity and Intestinal Colonization of Potentially Probiotic Lactic Acid Bacteria Administered during Calf Rearing. Livest. Sci. 2010, 128, 28–35. [Google Scholar] [CrossRef]
  33. Sun, P.; Wang, J.Q.; Zhang, H.T. Effects of Bacillus subtilis Natto on Performance and Immune Function of Preweaning Calves. J. Dairy Sci. 2010, 93, 5851–5855. [Google Scholar] [CrossRef] [PubMed]
  34. Wu, Y.; Wang, L.; Luo, R.; Chen, H.; Nie, C.; Niu, J.; Chen, C.; Xu, Y.; Li, X.; Zhang, W. Effect of a Multispecies Probiotic Mixture on the Growth and Incidence of Diarrhea, Immune Function, and Fecal Microbiota of Pre-Weaning Dairy Calves. Front. Microbiol. 2021, 12, 681014. [Google Scholar] [CrossRef] [PubMed]
  35. Noori, M.; Alikhani, M.; Jahanian, R. Effect of Partial Substitution of Milk with Probiotic Yogurt of Different pH on Performance, Body Conformation and Blood Biochemical Parameters of Holstein Calves. J. Appl. Anim. Res. 2016, 44, 221–229. [Google Scholar] [CrossRef]
  36. Williams, P. Bacillus subtilis: A Shocking Message from a Probiotic. Cell Host Microbe 2007, 1, 248–249. [Google Scholar] [CrossRef]
  37. Piewngam, P.; Zheng, Y.; Nguyen, T.H.; Dickey, S.W.; Joo, H.-S.; Villaruz, A.E.; Glose, K.A.; Fisher, E.L.; Hunt, R.L.; Li, B.; et al. Pathogen Elimination by Probiotic Bacillus via Signalling Interference. Nature 2018, 562, 532–537. [Google Scholar] [CrossRef]
  38. Diao, Q.; Zhang, R.; Fu, T. Review of Strategies to Promote Rumen Development in Calves. Animals 2019, 9, 490. [Google Scholar] [CrossRef]
  39. Cho, Y.; Yoon, K.-J. An Overview of Calf Diarrhea—Infectious Etiology, Diagnosis, and Intervention. J. Vet. Sci. 2014, 15, 1–17. [Google Scholar] [CrossRef]
  40. Klein, P.; Kleinová, T.; Volek, Z.; Šimůnek, J. Effect of Cryptosporidium parvum Infection on the Absorptive Capacity and Paracellular Permeability of the Small Intestine in Neonatal Calves. Vet. Parasitol. 2008, 152, 53–59. [Google Scholar] [CrossRef]
  41. Murray, G.M.; More, S.J.; Clegg, T.A.; Earley, B.; O’Neill, R.G.; Johnston, D.; Gilmore, J.; Nosov, M.; McElroy, M.C.; Inzana, T.J.; et al. Risk Factors Associated with Exposure to Bovine Respiratory Disease Pathogens during the Peri-Weaning Period in Dairy Bull Calves. BMC Vet. Res. 2018, 14, 53. [Google Scholar] [CrossRef]
  42. Medrano-Galarza, C.; Gibbons, J.; Wagner, S.; de Passillé, A.M.; Rushen, J. Behavioral Changes in Dairy Cows with Mastitis. J. Dairy Sci. 2012, 95, 6994–7002. [Google Scholar] [CrossRef] [PubMed]
  43. Du, R.; Jiao, S.; Dai, Y.; An, J.; Lv, J.; Yan, X.; Wang, J.; Han, B. Probiotic Bacillus amyloliquefaciens C-1 Improves Growth Performance, Stimulates GH/IGF-1, and Regulates the Gut Microbiota of Growth-Retarded Beef Calves. Front. Microbiol. 2018, 9, 2006. [Google Scholar] [CrossRef]
  44. Halachmi, I. Precision Livestock Farming Applications: Making Sense of Sensors to Support Farm Management; Wageningen Academic Publishers: Wageningen, The Netherlands, 2015; ISBN 978-90-8686-815-5. [Google Scholar]
  45. Gu, X.L.; Li, H.; Song, Z.H.; Ding, Y.N.; He, X.; Fan, Z.Y. Effects of Isomaltooligosaccharide and Bacillus Supplementation on Sow Performance, Serum Metabolites, and Serum and Placental Oxidative Status. Anim. Reprod. Sci. 2019, 207, 52–60. [Google Scholar] [CrossRef]
  46. Zimmerman, H.J.; Dujovne, C.A.; Levy, R. The Correlation of Serum Levels of Two Transaminases with Tissue Levels in Six Vertebrate Species. Comp. Biochem. Physiol. 1968, 25, 1081–1089. [Google Scholar] [CrossRef] [PubMed]
  47. Meyer: Veterinary Laboratory Medicine—Google Scholar. Available online: https://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&pages=157-187&author=DJ+Meyer&author=JW+Harvey&title=Veterinary+Laboratory+Medicine.+Interpretation+and+Diagnosis (accessed on 19 January 2024).
  48. Ramaiah, S.K. A Toxicologist Guide to the Diagnostic Interpretation of Hepatic Biochemical Parameters. Food Chem. Toxicol. 2007, 45, 1551–1557. [Google Scholar] [CrossRef]
  49. Lykkesfeldt, J.; Svendsen, O. Oxidants and Antioxidants in Disease: Oxidative Stress in Farm Animals. Vet. J. 2007, 173, 502–511. [Google Scholar] [CrossRef]
  50. Devyatkin, V.; Mishurov, A.; Kolodina, E. Probiotic Effect of Bacillus subtilis B-2998D, B-3057D, and Bacillus licheniformis B-2999D Complex on Sheep and Lambs. J. Adv. Vet. Anim. Res. 2021, 8, 146–157. [Google Scholar] [CrossRef]
  51. Choonkham, W.; Intanon, M.; Chewonarin, T.; Bernard, J.K.; Suriyasathaporn, W. Effects of Supplemental Bacillus subtilis, Injectable Vitamin E plus Selenium, or Both on Health Parameters during the Transition Period in Dairy Cows in a Tropical Environment. Trop. Anim. Health Prod. 2021, 53, 298. [Google Scholar] [CrossRef] [PubMed]
  52. Pekcan, M.; Fıdancı, U.R.; Yuceer, B.; Ozbeyaz, C. Estimation of Passive Immunity in Newborn Calves with Routine Clinical Chemistry Measurements. Ank. Üniversitesi Vet. Fakültesi Derg. 2013, 60, 85–88. [Google Scholar] [CrossRef]
  53. Krehbiel, C.R.; Rust, S.R.; Zhang, G.; Gilliland, S.E. Bacterial Direct-Fed Microbials in Ruminant Diets: Performance Response and Mode of Action12. J. Anim. Sci. 2003, 81, E120–E132. [Google Scholar] [CrossRef]
  54. Zhang, R.; Zhou, M.; Tu, Y.; Zhang, N.F.; Deng, K.D.; Ma, T.; Diao, Q.Y. Effect of Oral Administration of Probiotics on Growth Performance, Apparent Nutrient Digestibility and Stress-Related Indicators in Holstein Calves. J. Anim. Physiol. Anim. Nutr. 2016, 100, 33–38. [Google Scholar] [CrossRef] [PubMed]
  55. Fuller, R. Probiotics in Man and Animals. J. Appl. Bacteriol. 1989, 66, 365–378. [Google Scholar]
  56. Wilms, J.N.; Ghaffari, M.H.; Darani, P.S.; Jansen, M.; Sauerwein, H.; Steele, M.A.; Martín-Tereso, J.; Leal, L.N. Postprandial Metabolism and Gut Permeability in Calves Fed Milk Replacer with Different Macronutrient Profiles or a Whole Milk Powder. J. Dairy Sci. 2024, 107, 184–201. [Google Scholar] [CrossRef] [PubMed]
  57. Li, Y.; Li, X.; Nie, C.; Wu, Y.; Luo, R.; Chen, C.; Niu, J.; Zhang, W. Effects of Two Strains of Lactobacillus Isolated from the Feces of Calves after Fecal Microbiota Transplantation on Growth Performance, Immune Capacity, and Intestinal Barrier Function of Weaned Calves. Front. Microbiol. 2023, 14, 1249628. [Google Scholar] [CrossRef]
  58. Zábranský, L.; Poborská, A.; Gálik, B.; Šoch, M.; Brož, P.; Kantor, M.; Kernerová, N.; Řezáč, I.; Rolinec, M.; Hanušovský, O.; et al. Influence of Probiotic Strains Bifidobacterium, Lactobacillus, and Enterococcus on the Health Status and Weight Gain of Calves, and the Utilization of Nitrogenous Compounds. Antibiotics 2022, 11, 1273. [Google Scholar] [CrossRef]
Table 1. Composition and potency of the milk replacer.
Table 1. Composition and potency of the milk replacer.
CompositionAmountUnits
Crude protein22.0%
Crude fat18.0%
Fiber0.0%
Ash6.5%
Lysine17.5g/kg
Methionine5.0g/kg
Calcium7.5g/kg
Sodium4.4g/kg
Phosphorus6.3g/kg
Vegetable fat18.0%
Hydrolysed wheat protein concentrate7.5%
Dextrose2.0%
Vitamins and trace elements2.5%
Potency
Bacillus subtilis concentration5 × 107 CFU/mL
Table 2. Composition of calf starter ingredients.
Table 2. Composition of calf starter ingredients.
NutrientAmountUnits
Dry matter (DM) 88.82%
Crude protein (CP)21.10% of DM
Soluble protein 27.83%CP
Ammonium 0.00% of DM
Acid detergent insoluble protein 0.75% of DM
Neutral detergent insoluble protein 1.79% of DM
Acid detergent fibre 10.89% of DM
Ammonia neutral detergent fibre on an organic matter basis 18.28% of DM
Physically effective fibre as a percentage of neutral detergent fibre 37.81% of NDF
Lignin1.93% of DM
Non-fibre carbohydrates 47.14% of DM
Sugar 6.96% of DM
Starch 23.20% of DM
Soluble fibre 6.97% of DM
Ether extract 4.04% of DM
Ash 9.45% of DM
Calcium 1.01% of DM
Phosphorus 0.66% of DM
Magnesium0.38% of DM
Potassium1.14% of DM
Sulphur 0.26% of DM
Natrium 0.50% of DM
Chloride 0.24% of DM
Iron 132.59ppm
Zinc 76.39ppm
Copper 44.90ppm
Magnesium40.88ppm
Selenium 1.90ppm
Cobalt 1.90ppm
Iodide 3.65ppm
Vitamin A 31.63IU/kg
Vitamin D 13.53IU/kg
Vitamin E 288.87IU/kg
Table 3. Body weight of dairy calves fed B. subtilis supplement (0.5 mL/calf/day) compared to the control group.
Table 3. Body weight of dairy calves fed B. subtilis supplement (0.5 mL/calf/day) compared to the control group.
BW (kg)GroupNMeanStd. Errorp
0 d.CG2534.542.050.737
TG2535.481.86
15 d. CG2544.212.050.966
TG2544.352.68
30 d.CG2552.712.050.048
TG2554.382.687
60 d.CG2576.342.050.045
TG2579.211.86
90 d.CG25109.671.670.032
TG25112.871.95
BW—body weigh; 0 d.—body weight at birth; 15 d.—body weight at 15 days of age; 30 d.—body weight at 30 days of age; 60 d.—body weight at 60 days of age; 90 d.—body weight at 90 days of age. CG—control group; TG—B. subtilis-supplement-treated group.
Table 4. Faecal score of dairy calves fed B. subtilis supplement (0.5 mL/calf/day) compared to the control group.
Table 4. Faecal score of dairy calves fed B. subtilis supplement (0.5 mL/calf/day) compared to the control group.
FSGroupNMeanStd. Errorp
0 d.CG251.670.0430.87
TG251.560.042
15 d.CG252.760.0340.09
TG252.250.095
30 d.CG251.540.0420.16
TG251.670.049
60 d.CG251.430.0670.65
TG251.540.043
90 d.CG251.540.0760.56
TG251.160.056
FS—faecal score; 0 d.—faecal score at birth; 15 d.—faecal score at 15 days of age; 30 d.—faecal score at 30 days of age; 60 d.—faecal score at 60 days of age; 90 d.—faecal score at 90 days of age. CG—control group; TG—B. subtilis-supplement-treated group.
Table 5. Respiratory and digestive disorders of dairy calves fed B. subtilis supplement (0.5 mL/calf/day) compared to the control group.
Table 5. Respiratory and digestive disorders of dairy calves fed B. subtilis supplement (0.5 mL/calf/day) compared to the control group.
GroupNNumber of Respiratory DisordersNumber of Digestive Disorders
0 d.CG2502
TG2502
15 d. CG25011
TG2503
30 d.CG2552
TG2513
60 d.CG2531
TG2501
90 d.CG2501
TG2501
0 d.—age at birth; 15 d.—15 days of age; 30 d.—30 days of age; 60 d.—60 days of age; 90 d.—90 days of age. CG—control group; TG—B. subtilis-supplement-treated group.
Table 6. AST activity of dairy calves fed B. subtilis supplement (0.5 mL/calf/day) compared to the control group.
Table 6. AST activity of dairy calves fed B. subtilis supplement (0.5 mL/calf/day) compared to the control group.
AST (IU/L)GroupNMeanStd. Errorp
0 d.CG2571.146.790.35
TG2554.892.99
30 d.CG2572.002.53<0.001
TG2562.020.97
60 d.CG2583.782.530.543
TG2579.450.97
90 d.CG2566.641.530.67
TG2565.671.32
AST (IU/L)—aspartate transaminase; 0 d.—AST activity at birth; 30 d.—AST activity at 30 days of age; 60 d.—AST activity at 60 days of age; 90 d.—AST activity at 90 days of age. CG—control group; TG—B. subtilis-supplement-treated group.
Table 7. GGT activity of dairy calves fed B. subtilis supplement (0.5 mL/calf/day) compared to the control group.
Table 7. GGT activity of dairy calves fed B. subtilis supplement (0.5 mL/calf/day) compared to the control group.
GGT (IU/L)GroupNMeanStd. Errorp
0 d.CG25349.1181.260.168
TG25496.6966.64
30 d.CG2514.350.72<0.001
TG2540.644.23
60 d.CG2532.540.80.154
TG2537.451.55
90 d.CG2525.540.80.143
TG2528.651.55
GGT (IU/L)—gamma-glutamyl transferase; 0 d.—GGT activity at birth; 30 d.—GGT activity at 30 days of age; 60 d.—GGT activity at 60 days of age; 90 d.—GGT activity at 90 days of age. CG—control group; TG—B. subtilis-supplement-treated group.
Table 8. Phosphorus concentration of dairy calves fed B. subtilis supplement (0.5 mL/calf/day) compared to the control group.
Table 8. Phosphorus concentration of dairy calves fed B. subtilis supplement (0.5 mL/calf/day) compared to the control group.
P (mmol/L)GroupNMeanStd. Errorp
0 d.CG252.440.060.745
TG252.910.1
30 d.CG252.990.05<0.001
TG253.270.04
60 d.CG253.220.080.54
TG253.110.03
90 d.CG253.320.040.45
TG253.220.06
P (mmol/L)—phosphorus; 0 d.—phosphorus concentration at birth; 30 d.—phosphorus concentration at 30 days of age; 60 d.—phosphorus concentration at 60 days of age; 90 d.—phosphorus concentration at 90 days of age. CG—control group; TG—B. subtilis-supplement-treated group.
Table 9. Total protein concentration of dairy calves fed B. subtilis supplement (0.5 mL/calf/day) compared to the control group.
Table 9. Total protein concentration of dairy calves fed B. subtilis supplement (0.5 mL/calf/day) compared to the control group.
TP (g/L)GroupNMeanStd. Errorp
0 d.CG2547.562.010.56
TG2549.332.29
30 d.CG2556.341.960.014
TG2546.323.29
60 d.CG2558.121.550.045
TG2548.322.29
90 d.CG2560.223.550.055
TG2555.543.29
TP (g/L)—total protein; 0 d.—total protein concentration at birth; 30 d.—total protein concentration at 30 days of age; 60 d.—total protein concentration at 60 days of age; 90 d.—total protein concentration at 90 days of age. CG—control group; TG—B. subtilis-supplement-treated group.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Antanaitis, R.; Džermeikaitė, K.; Krištolaitytė, J.; Armonavičiūtė, E.; Arlauskaitė, S.; Girdauskaitė, A.; Rutkauskas, A.; Baumgartner, W. Effects of Bacillus subtilis on Growth Performance, Metabolic Profile, and Health Status in Dairy Calves. Animals 2024, 14, 2489. https://doi.org/10.3390/ani14172489

AMA Style

Antanaitis R, Džermeikaitė K, Krištolaitytė J, Armonavičiūtė E, Arlauskaitė S, Girdauskaitė A, Rutkauskas A, Baumgartner W. Effects of Bacillus subtilis on Growth Performance, Metabolic Profile, and Health Status in Dairy Calves. Animals. 2024; 14(17):2489. https://doi.org/10.3390/ani14172489

Chicago/Turabian Style

Antanaitis, Ramūnas, Karina Džermeikaitė, Justina Krištolaitytė, Emilija Armonavičiūtė, Samanta Arlauskaitė, Akvilė Girdauskaitė, Arūnas Rutkauskas, and Walter Baumgartner. 2024. "Effects of Bacillus subtilis on Growth Performance, Metabolic Profile, and Health Status in Dairy Calves" Animals 14, no. 17: 2489. https://doi.org/10.3390/ani14172489

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop